nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0836	0.143	CbGbCtD
Etoricoxib—PTGS2—Etoposide—uterine cancer	0.0729	0.124	CbGbCtD
Etoricoxib—CYP2C19—Progesterone—uterine cancer	0.0666	0.114	CbGbCtD
Etoricoxib—CYP1A2—Progesterone—uterine cancer	0.0614	0.105	CbGbCtD
Etoricoxib—CYP2C9—Progesterone—uterine cancer	0.0553	0.0945	CbGbCtD
Etoricoxib—CYP2D6—Progesterone—uterine cancer	0.0506	0.0864	CbGbCtD
Etoricoxib—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0486	0.0829	CbGbCtD
Etoricoxib—CYP2E1—Etoposide—uterine cancer	0.0475	0.0811	CbGbCtD
Etoricoxib—CYP3A4—Progesterone—uterine cancer	0.0322	0.0549	CbGbCtD
Etoricoxib—CYP1A2—Etoposide—uterine cancer	0.0275	0.0469	CbGbCtD
Etoricoxib—CYP2D6—Doxorubicin—uterine cancer	0.0154	0.0264	CbGbCtD
Etoricoxib—CYP3A4—Etoposide—uterine cancer	0.0144	0.0246	CbGbCtD
Etoricoxib—CYP3A4—Doxorubicin—uterine cancer	0.00982	0.0168	CbGbCtD
Etoricoxib—MAPK14—epithelium—uterine cancer	0.00243	0.0713	CbGeAlD
Etoricoxib—MAPK14—uterine cervix—uterine cancer	0.00241	0.0707	CbGeAlD
Etoricoxib—MAPK14—smooth muscle tissue—uterine cancer	0.00235	0.0687	CbGeAlD
Etoricoxib—MAPK14—decidua—uterine cancer	0.0023	0.0674	CbGeAlD
Etoricoxib—MAPK14—renal system—uterine cancer	0.00226	0.0662	CbGeAlD
Etoricoxib—MAPK14—uterus—uterine cancer	0.00201	0.059	CbGeAlD
Etoricoxib—PTGS2—artery—uterine cancer	0.00185	0.0541	CbGeAlD
Etoricoxib—MAPK14—female reproductive system—uterine cancer	0.00181	0.053	CbGeAlD
Etoricoxib—MAPK14—female gonad—uterine cancer	0.00165	0.0482	CbGeAlD
Etoricoxib—MAPK14—vagina—uterine cancer	0.00164	0.0479	CbGeAlD
Etoricoxib—MAPK14—lymph node—uterine cancer	0.00106	0.031	CbGeAlD
Etoricoxib—PTGS2—myometrium—uterine cancer	0.000892	0.0261	CbGeAlD
Etoricoxib—CYP1A2—renal system—uterine cancer	0.000784	0.023	CbGeAlD
Etoricoxib—CYP2E1—renal system—uterine cancer	0.000705	0.0207	CbGeAlD
Etoricoxib—PTGS2—epithelium—uterine cancer	0.0007	0.0205	CbGeAlD
Etoricoxib—CYP2C19—vagina—uterine cancer	0.000695	0.0204	CbGeAlD
Etoricoxib—PTGS2—uterine cervix—uterine cancer	0.000694	0.0203	CbGeAlD
Etoricoxib—PTGS2—smooth muscle tissue—uterine cancer	0.000675	0.0198	CbGeAlD
Etoricoxib—PTGS2—renal system—uterine cancer	0.000649	0.019	CbGeAlD
Etoricoxib—PTGS2—endometrium—uterine cancer	0.000628	0.0184	CbGeAlD
Etoricoxib—CYP2C9—female reproductive system—uterine cancer	0.000596	0.0175	CbGeAlD
Etoricoxib—PTGS2—uterus—uterine cancer	0.000579	0.017	CbGeAlD
Etoricoxib—CYP3A4—renal system—uterine cancer	0.000568	0.0166	CbGeAlD
Etoricoxib—CYP2E1—female reproductive system—uterine cancer	0.000565	0.0166	CbGeAlD
Etoricoxib—CYP2D6—renal system—uterine cancer	0.000558	0.0164	CbGeAlD
Etoricoxib—PTGS2—female reproductive system—uterine cancer	0.00052	0.0152	CbGeAlD
Etoricoxib—PTGS2—female gonad—uterine cancer	0.000473	0.0139	CbGeAlD
Etoricoxib—PTGS2—vagina—uterine cancer	0.00047	0.0138	CbGeAlD
Etoricoxib—CYP3A4—female reproductive system—uterine cancer	0.000455	0.0133	CbGeAlD
Etoricoxib—CYP2D6—female reproductive system—uterine cancer	0.000447	0.0131	CbGeAlD
Etoricoxib—CYP2D6—female gonad—uterine cancer	0.000407	0.0119	CbGeAlD
Etoricoxib—PTGS2—lymph node—uterine cancer	0.000304	0.00892	CbGeAlD
Etoricoxib—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00024	0.000926	CcSEcCtD
Etoricoxib—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000238	0.000919	CcSEcCtD
Etoricoxib—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000238	0.000918	CcSEcCtD
Etoricoxib—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000236	0.000913	CcSEcCtD
Etoricoxib—Renal impairment—Doxorubicin—uterine cancer	0.000236	0.000912	CcSEcCtD
Etoricoxib—Abdominal pain—Dactinomycin—uterine cancer	0.000233	0.000898	CcSEcCtD
Etoricoxib—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000232	0.000897	CcSEcCtD
Etoricoxib—Cardiac arrest—Epirubicin—uterine cancer	0.000231	0.000892	CcSEcCtD
Etoricoxib—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00023	0.000886	CcSEcCtD
Etoricoxib—Cough—Etoposide—uterine cancer	0.000228	0.000879	CcSEcCtD
Etoricoxib—Blood creatinine increased—Epirubicin—uterine cancer	0.000228	0.000879	CcSEcCtD
Etoricoxib—Hypertension—Etoposide—uterine cancer	0.000225	0.00087	CcSEcCtD
Etoricoxib—Pain in extremity—Doxorubicin—uterine cancer	0.000225	0.000868	CcSEcCtD
Etoricoxib—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000225	0.000868	CcSEcCtD
Etoricoxib—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000224	0.000865	CcSEcCtD
Etoricoxib—Chest pain—Etoposide—uterine cancer	0.000222	0.000858	CcSEcCtD
Etoricoxib—Orthostatic hypotension—Epirubicin—uterine cancer	0.000222	0.000857	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000221	0.000852	CcSEcCtD
Etoricoxib—Breast disorder—Epirubicin—uterine cancer	0.00022	0.000848	CcSEcCtD
Etoricoxib—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000219	0.000845	CcSEcCtD
Etoricoxib—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000219	0.000845	CcSEcCtD
Etoricoxib—Hypersensitivity—Dactinomycin—uterine cancer	0.000217	0.000837	CcSEcCtD
Etoricoxib—Gastritis—Epirubicin—uterine cancer	0.000215	0.00083	CcSEcCtD
Etoricoxib—Confusional state—Etoposide—uterine cancer	0.000215	0.000829	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000214	0.000827	CcSEcCtD
Etoricoxib—Muscular weakness—Epirubicin—uterine cancer	0.000214	0.000827	CcSEcCtD
Etoricoxib—Cardiac arrest—Doxorubicin—uterine cancer	0.000214	0.000825	CcSEcCtD
Etoricoxib—Anaphylactic shock—Etoposide—uterine cancer	0.000213	0.000822	CcSEcCtD
Etoricoxib—Infection—Etoposide—uterine cancer	0.000212	0.000817	CcSEcCtD
Etoricoxib—Abdominal distension—Epirubicin—uterine cancer	0.000211	0.000816	CcSEcCtD
Etoricoxib—Asthenia—Dactinomycin—uterine cancer	0.000211	0.000815	CcSEcCtD
Etoricoxib—Blood creatinine increased—Doxorubicin—uterine cancer	0.000211	0.000813	CcSEcCtD
Etoricoxib—Thrombocytopenia—Etoposide—uterine cancer	0.000209	0.000805	CcSEcCtD
Etoricoxib—Skin disorder—Etoposide—uterine cancer	0.000207	0.000799	CcSEcCtD
Etoricoxib—Pancreatitis—Epirubicin—uterine cancer	0.000206	0.000795	CcSEcCtD
Etoricoxib—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000205	0.000793	CcSEcCtD
Etoricoxib—Angina pectoris—Epirubicin—uterine cancer	0.000205	0.00079	CcSEcCtD
Etoricoxib—Breast disorder—Doxorubicin—uterine cancer	0.000203	0.000784	CcSEcCtD
Etoricoxib—Anorexia—Etoposide—uterine cancer	0.000203	0.000784	CcSEcCtD
Etoricoxib—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000203	0.000781	CcSEcCtD
Etoricoxib—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000203	0.000781	CcSEcCtD
Etoricoxib—Bronchitis—Epirubicin—uterine cancer	0.000202	0.00078	CcSEcCtD
Etoricoxib—Diarrhoea—Dactinomycin—uterine cancer	0.000201	0.000777	CcSEcCtD
Etoricoxib—Gastritis—Doxorubicin—uterine cancer	0.000199	0.000768	CcSEcCtD
Etoricoxib—Muscular weakness—Doxorubicin—uterine cancer	0.000198	0.000765	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000198	0.000765	CcSEcCtD
Etoricoxib—Abdominal distension—Doxorubicin—uterine cancer	0.000196	0.000755	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000195	0.000753	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Epirubicin—uterine cancer	0.000192	0.00074	CcSEcCtD
Etoricoxib—Weight increased—Epirubicin—uterine cancer	0.000191	0.000738	CcSEcCtD
Etoricoxib—Pancreatitis—Doxorubicin—uterine cancer	0.000191	0.000735	CcSEcCtD
Etoricoxib—Dyspnoea—Etoposide—uterine cancer	0.00019	0.000733	CcSEcCtD
Etoricoxib—Hyperglycaemia—Epirubicin—uterine cancer	0.00019	0.000731	CcSEcCtD
Etoricoxib—Somnolence—Etoposide—uterine cancer	0.000189	0.000731	CcSEcCtD
Etoricoxib—Angina pectoris—Doxorubicin—uterine cancer	0.000189	0.000731	CcSEcCtD
Etoricoxib—Pneumonia—Epirubicin—uterine cancer	0.000188	0.000727	CcSEcCtD
Etoricoxib—Infestation NOS—Epirubicin—uterine cancer	0.000187	0.000723	CcSEcCtD
Etoricoxib—Infestation—Epirubicin—uterine cancer	0.000187	0.000723	CcSEcCtD
Etoricoxib—Vomiting—Dactinomycin—uterine cancer	0.000187	0.000722	CcSEcCtD
Etoricoxib—Bronchitis—Doxorubicin—uterine cancer	0.000187	0.000721	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000186	0.000717	CcSEcCtD
Etoricoxib—Rash—Dactinomycin—uterine cancer	0.000186	0.000716	CcSEcCtD
Etoricoxib—Decreased appetite—Etoposide—uterine cancer	0.000185	0.000715	CcSEcCtD
Etoricoxib—Renal failure—Epirubicin—uterine cancer	0.000184	0.000711	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Etoposide—uterine cancer	0.000184	0.00071	CcSEcCtD
Etoricoxib—Fatigue—Etoposide—uterine cancer	0.000184	0.000709	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Epirubicin—uterine cancer	0.000184	0.000709	CcSEcCtD
Etoricoxib—Jaundice—Epirubicin—uterine cancer	0.000183	0.000705	CcSEcCtD
Etoricoxib—Stomatitis—Epirubicin—uterine cancer	0.000183	0.000705	CcSEcCtD
Etoricoxib—Constipation—Etoposide—uterine cancer	0.000182	0.000703	CcSEcCtD
Etoricoxib—Pain—Etoposide—uterine cancer	0.000182	0.000703	CcSEcCtD
Etoricoxib—Conjunctivitis—Epirubicin—uterine cancer	0.000182	0.000703	CcSEcCtD
Etoricoxib—Urinary tract infection—Epirubicin—uterine cancer	0.000182	0.000703	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000181	0.000697	CcSEcCtD
Etoricoxib—Haematuria—Epirubicin—uterine cancer	0.000179	0.000689	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000177	0.000685	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Epirubicin—uterine cancer	0.000177	0.000684	CcSEcCtD
Etoricoxib—Weight increased—Doxorubicin—uterine cancer	0.000177	0.000683	CcSEcCtD
Etoricoxib—Epistaxis—Epirubicin—uterine cancer	0.000177	0.000682	CcSEcCtD
Etoricoxib—Sinusitis—Epirubicin—uterine cancer	0.000176	0.000678	CcSEcCtD
Etoricoxib—Feeling abnormal—Etoposide—uterine cancer	0.000176	0.000678	CcSEcCtD
Etoricoxib—Hyperglycaemia—Doxorubicin—uterine cancer	0.000175	0.000677	CcSEcCtD
Etoricoxib—Nausea—Dactinomycin—uterine cancer	0.000175	0.000675	CcSEcCtD
Etoricoxib—Pneumonia—Doxorubicin—uterine cancer	0.000174	0.000673	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Etoposide—uterine cancer	0.000174	0.000672	CcSEcCtD
Etoricoxib—Infestation—Doxorubicin—uterine cancer	0.000173	0.000669	CcSEcCtD
Etoricoxib—Infestation NOS—Doxorubicin—uterine cancer	0.000173	0.000669	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000172	0.000663	CcSEcCtD
Etoricoxib—Renal failure—Doxorubicin—uterine cancer	0.00017	0.000657	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Doxorubicin—uterine cancer	0.00017	0.000656	CcSEcCtD
Etoricoxib—Urticaria—Etoposide—uterine cancer	0.000169	0.000653	CcSEcCtD
Etoricoxib—Haemoglobin—Epirubicin—uterine cancer	0.000169	0.000652	CcSEcCtD
Etoricoxib—Stomatitis—Doxorubicin—uterine cancer	0.000169	0.000652	CcSEcCtD
Etoricoxib—Jaundice—Doxorubicin—uterine cancer	0.000169	0.000652	CcSEcCtD
Etoricoxib—Abdominal pain—Etoposide—uterine cancer	0.000168	0.00065	CcSEcCtD
Etoricoxib—Conjunctivitis—Doxorubicin—uterine cancer	0.000168	0.00065	CcSEcCtD
Etoricoxib—Urinary tract infection—Doxorubicin—uterine cancer	0.000168	0.00065	CcSEcCtD
Etoricoxib—Haemorrhage—Epirubicin—uterine cancer	0.000168	0.000649	CcSEcCtD
Etoricoxib—Hepatitis—Epirubicin—uterine cancer	0.000168	0.000649	CcSEcCtD
Etoricoxib—Hypoaesthesia—Epirubicin—uterine cancer	0.000167	0.000646	CcSEcCtD
Etoricoxib—Pharyngitis—Epirubicin—uterine cancer	0.000167	0.000644	CcSEcCtD
Etoricoxib—Urinary tract disorder—Epirubicin—uterine cancer	0.000166	0.000641	CcSEcCtD
Etoricoxib—Oedema peripheral—Epirubicin—uterine cancer	0.000166	0.000639	CcSEcCtD
Etoricoxib—Haematuria—Doxorubicin—uterine cancer	0.000165	0.000638	CcSEcCtD
Etoricoxib—Connective tissue disorder—Epirubicin—uterine cancer	0.000165	0.000638	CcSEcCtD
Etoricoxib—Urethral disorder—Epirubicin—uterine cancer	0.000165	0.000636	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000164	0.000633	CcSEcCtD
Etoricoxib—Epistaxis—Doxorubicin—uterine cancer	0.000163	0.000631	CcSEcCtD
Etoricoxib—Sinusitis—Doxorubicin—uterine cancer	0.000163	0.000627	CcSEcCtD
Etoricoxib—Visual impairment—Epirubicin—uterine cancer	0.000162	0.000625	CcSEcCtD
Etoricoxib—Erythema multiforme—Epirubicin—uterine cancer	0.000159	0.000614	CcSEcCtD
Etoricoxib—Eye disorder—Epirubicin—uterine cancer	0.000157	0.000606	CcSEcCtD
Etoricoxib—Hypersensitivity—Etoposide—uterine cancer	0.000157	0.000606	CcSEcCtD
Etoricoxib—Tinnitus—Epirubicin—uterine cancer	0.000157	0.000605	CcSEcCtD
Etoricoxib—Haemoglobin—Doxorubicin—uterine cancer	0.000156	0.000603	CcSEcCtD
Etoricoxib—Cardiac disorder—Epirubicin—uterine cancer	0.000156	0.000602	CcSEcCtD
Etoricoxib—Flushing—Epirubicin—uterine cancer	0.000156	0.000602	CcSEcCtD
Etoricoxib—Haemorrhage—Doxorubicin—uterine cancer	0.000156	0.0006	CcSEcCtD
Etoricoxib—Hepatitis—Doxorubicin—uterine cancer	0.000156	0.0006	CcSEcCtD
Etoricoxib—Hypoaesthesia—Doxorubicin—uterine cancer	0.000155	0.000597	CcSEcCtD
Etoricoxib—Pharyngitis—Doxorubicin—uterine cancer	0.000154	0.000596	CcSEcCtD
Etoricoxib—Urinary tract disorder—Doxorubicin—uterine cancer	0.000154	0.000593	CcSEcCtD
Etoricoxib—Oedema peripheral—Doxorubicin—uterine cancer	0.000153	0.000591	CcSEcCtD
Etoricoxib—Asthenia—Etoposide—uterine cancer	0.000153	0.00059	CcSEcCtD
Etoricoxib—Connective tissue disorder—Doxorubicin—uterine cancer	0.000153	0.00059	CcSEcCtD
Etoricoxib—Angiopathy—Epirubicin—uterine cancer	0.000153	0.000589	CcSEcCtD
Etoricoxib—Urethral disorder—Doxorubicin—uterine cancer	0.000153	0.000589	CcSEcCtD
Etoricoxib—Immune system disorder—Epirubicin—uterine cancer	0.000152	0.000586	CcSEcCtD
Etoricoxib—Mediastinal disorder—Epirubicin—uterine cancer	0.000152	0.000585	CcSEcCtD
Etoricoxib—Pruritus—Etoposide—uterine cancer	0.000151	0.000582	CcSEcCtD
Etoricoxib—Arrhythmia—Epirubicin—uterine cancer	0.00015	0.00058	CcSEcCtD
Etoricoxib—Visual impairment—Doxorubicin—uterine cancer	0.00015	0.000579	CcSEcCtD
Etoricoxib—Alopecia—Epirubicin—uterine cancer	0.000149	0.000573	CcSEcCtD
Etoricoxib—Mental disorder—Epirubicin—uterine cancer	0.000147	0.000568	CcSEcCtD
Etoricoxib—Erythema multiforme—Doxorubicin—uterine cancer	0.000147	0.000568	CcSEcCtD
Etoricoxib—Erythema—Epirubicin—uterine cancer	0.000146	0.000565	CcSEcCtD
Etoricoxib—Malnutrition—Epirubicin—uterine cancer	0.000146	0.000565	CcSEcCtD
Etoricoxib—Diarrhoea—Etoposide—uterine cancer	0.000146	0.000563	CcSEcCtD
Etoricoxib—Eye disorder—Doxorubicin—uterine cancer	0.000145	0.000561	CcSEcCtD
Etoricoxib—Tinnitus—Doxorubicin—uterine cancer	0.000145	0.00056	CcSEcCtD
Etoricoxib—Cardiac disorder—Doxorubicin—uterine cancer	0.000144	0.000557	CcSEcCtD
Etoricoxib—Flushing—Doxorubicin—uterine cancer	0.000144	0.000557	CcSEcCtD
Etoricoxib—Flatulence—Epirubicin—uterine cancer	0.000144	0.000557	CcSEcCtD
Etoricoxib—Dysgeusia—Epirubicin—uterine cancer	0.000143	0.000553	CcSEcCtD
Etoricoxib—Angiopathy—Doxorubicin—uterine cancer	0.000141	0.000545	CcSEcCtD
Etoricoxib—Dizziness—Etoposide—uterine cancer	0.000141	0.000544	CcSEcCtD
Etoricoxib—Muscle spasms—Epirubicin—uterine cancer	0.000141	0.000543	CcSEcCtD
Etoricoxib—Immune system disorder—Doxorubicin—uterine cancer	0.000141	0.000542	CcSEcCtD
Etoricoxib—Mediastinal disorder—Doxorubicin—uterine cancer	0.00014	0.000541	CcSEcCtD
Etoricoxib—Arrhythmia—Doxorubicin—uterine cancer	0.000139	0.000536	CcSEcCtD
Etoricoxib—Vision blurred—Epirubicin—uterine cancer	0.000138	0.000532	CcSEcCtD
Etoricoxib—Alopecia—Doxorubicin—uterine cancer	0.000137	0.000531	CcSEcCtD
Etoricoxib—Mental disorder—Doxorubicin—uterine cancer	0.000136	0.000526	CcSEcCtD
Etoricoxib—Vomiting—Etoposide—uterine cancer	0.000136	0.000523	CcSEcCtD
Etoricoxib—Erythema—Doxorubicin—uterine cancer	0.000135	0.000523	CcSEcCtD
Etoricoxib—Malnutrition—Doxorubicin—uterine cancer	0.000135	0.000523	CcSEcCtD
Etoricoxib—Anaemia—Epirubicin—uterine cancer	0.000135	0.000522	CcSEcCtD
Etoricoxib—Agitation—Epirubicin—uterine cancer	0.000135	0.000519	CcSEcCtD
Etoricoxib—Rash—Etoposide—uterine cancer	0.000134	0.000519	CcSEcCtD
Etoricoxib—Dermatitis—Etoposide—uterine cancer	0.000134	0.000518	CcSEcCtD
Etoricoxib—Headache—Etoposide—uterine cancer	0.000134	0.000515	CcSEcCtD
Etoricoxib—Flatulence—Doxorubicin—uterine cancer	0.000133	0.000515	CcSEcCtD
Etoricoxib—Dysgeusia—Doxorubicin—uterine cancer	0.000133	0.000512	CcSEcCtD
Etoricoxib—Muscle spasms—Doxorubicin—uterine cancer	0.00013	0.000502	CcSEcCtD
Etoricoxib—Palpitations—Epirubicin—uterine cancer	0.000129	0.000499	CcSEcCtD
Etoricoxib—Cough—Epirubicin—uterine cancer	0.000128	0.000493	CcSEcCtD
Etoricoxib—Vision blurred—Doxorubicin—uterine cancer	0.000128	0.000493	CcSEcCtD
Etoricoxib—Nausea—Etoposide—uterine cancer	0.000127	0.000488	CcSEcCtD
Etoricoxib—Hypertension—Epirubicin—uterine cancer	0.000126	0.000488	CcSEcCtD
Etoricoxib—Anaemia—Doxorubicin—uterine cancer	0.000125	0.000483	CcSEcCtD
Etoricoxib—Arthralgia—Epirubicin—uterine cancer	0.000125	0.000481	CcSEcCtD
Etoricoxib—Chest pain—Epirubicin—uterine cancer	0.000125	0.000481	CcSEcCtD
Etoricoxib—Agitation—Doxorubicin—uterine cancer	0.000124	0.00048	CcSEcCtD
Etoricoxib—Anxiety—Epirubicin—uterine cancer	0.000124	0.000479	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000124	0.000478	CcSEcCtD
Etoricoxib—Dry mouth—Epirubicin—uterine cancer	0.000122	0.00047	CcSEcCtD
Etoricoxib—Confusional state—Epirubicin—uterine cancer	0.00012	0.000465	CcSEcCtD
Etoricoxib—Palpitations—Doxorubicin—uterine cancer	0.00012	0.000462	CcSEcCtD
Etoricoxib—Anaphylactic shock—Epirubicin—uterine cancer	0.000119	0.000461	CcSEcCtD
Etoricoxib—Oedema—Epirubicin—uterine cancer	0.000119	0.000461	CcSEcCtD
Etoricoxib—Infection—Epirubicin—uterine cancer	0.000119	0.000458	CcSEcCtD
Etoricoxib—Cough—Doxorubicin—uterine cancer	0.000118	0.000456	CcSEcCtD
Etoricoxib—Shock—Epirubicin—uterine cancer	0.000118	0.000454	CcSEcCtD
Etoricoxib—Nervous system disorder—Epirubicin—uterine cancer	0.000117	0.000452	CcSEcCtD
Etoricoxib—Thrombocytopenia—Epirubicin—uterine cancer	0.000117	0.000451	CcSEcCtD
Etoricoxib—Hypertension—Doxorubicin—uterine cancer	0.000117	0.000451	CcSEcCtD
Etoricoxib—Skin disorder—Epirubicin—uterine cancer	0.000116	0.000448	CcSEcCtD
Etoricoxib—Chest pain—Doxorubicin—uterine cancer	0.000115	0.000445	CcSEcCtD
Etoricoxib—Arthralgia—Doxorubicin—uterine cancer	0.000115	0.000445	CcSEcCtD
Etoricoxib—Anxiety—Doxorubicin—uterine cancer	0.000115	0.000443	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000115	0.000442	CcSEcCtD
Etoricoxib—Anorexia—Epirubicin—uterine cancer	0.000114	0.000439	CcSEcCtD
Etoricoxib—Dry mouth—Doxorubicin—uterine cancer	0.000113	0.000435	CcSEcCtD
Etoricoxib—Confusional state—Doxorubicin—uterine cancer	0.000111	0.00043	CcSEcCtD
Etoricoxib—Anaphylactic shock—Doxorubicin—uterine cancer	0.000111	0.000427	CcSEcCtD
Etoricoxib—Oedema—Doxorubicin—uterine cancer	0.000111	0.000427	CcSEcCtD
Etoricoxib—Infection—Doxorubicin—uterine cancer	0.00011	0.000424	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000109	0.00042	CcSEcCtD
Etoricoxib—Shock—Doxorubicin—uterine cancer	0.000109	0.00042	CcSEcCtD
Etoricoxib—Nervous system disorder—Doxorubicin—uterine cancer	0.000108	0.000418	CcSEcCtD
Etoricoxib—Thrombocytopenia—Doxorubicin—uterine cancer	0.000108	0.000418	CcSEcCtD
Etoricoxib—Insomnia—Epirubicin—uterine cancer	0.000108	0.000417	CcSEcCtD
Etoricoxib—Skin disorder—Doxorubicin—uterine cancer	0.000107	0.000414	CcSEcCtD
Etoricoxib—Dyspnoea—Epirubicin—uterine cancer	0.000107	0.000411	CcSEcCtD
Etoricoxib—Somnolence—Epirubicin—uterine cancer	0.000106	0.00041	CcSEcCtD
Etoricoxib—Anorexia—Doxorubicin—uterine cancer	0.000105	0.000407	CcSEcCtD
Etoricoxib—Dyspepsia—Epirubicin—uterine cancer	0.000105	0.000406	CcSEcCtD
Etoricoxib—Decreased appetite—Epirubicin—uterine cancer	0.000104	0.000401	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000103	0.000398	CcSEcCtD
Etoricoxib—Fatigue—Epirubicin—uterine cancer	0.000103	0.000397	CcSEcCtD
Etoricoxib—Pain—Epirubicin—uterine cancer	0.000102	0.000394	CcSEcCtD
Etoricoxib—Constipation—Epirubicin—uterine cancer	0.000102	0.000394	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000101	0.000389	CcSEcCtD
Etoricoxib—Insomnia—Doxorubicin—uterine cancer	0.0001	0.000386	CcSEcCtD
Etoricoxib—Dyspnoea—Doxorubicin—uterine cancer	9.85e-05	0.00038	CcSEcCtD
Etoricoxib—Feeling abnormal—Epirubicin—uterine cancer	9.84e-05	0.00038	CcSEcCtD
Etoricoxib—Somnolence—Doxorubicin—uterine cancer	9.83e-05	0.000379	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Epirubicin—uterine cancer	9.77e-05	0.000377	CcSEcCtD
Etoricoxib—Dyspepsia—Doxorubicin—uterine cancer	9.73e-05	0.000375	CcSEcCtD
Etoricoxib—Decreased appetite—Doxorubicin—uterine cancer	9.61e-05	0.000371	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Doxorubicin—uterine cancer	9.54e-05	0.000368	CcSEcCtD
Etoricoxib—Fatigue—Doxorubicin—uterine cancer	9.53e-05	0.000368	CcSEcCtD
Etoricoxib—Urticaria—Epirubicin—uterine cancer	9.49e-05	0.000366	CcSEcCtD
Etoricoxib—Pain—Doxorubicin—uterine cancer	9.45e-05	0.000365	CcSEcCtD
Etoricoxib—Constipation—Doxorubicin—uterine cancer	9.45e-05	0.000365	CcSEcCtD
Etoricoxib—Abdominal pain—Epirubicin—uterine cancer	9.44e-05	0.000364	CcSEcCtD
Etoricoxib—Feeling abnormal—Doxorubicin—uterine cancer	9.11e-05	0.000351	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Doxorubicin—uterine cancer	9.04e-05	0.000349	CcSEcCtD
Etoricoxib—Hypersensitivity—Epirubicin—uterine cancer	8.8e-05	0.00034	CcSEcCtD
Etoricoxib—Urticaria—Doxorubicin—uterine cancer	8.78e-05	0.000339	CcSEcCtD
Etoricoxib—Abdominal pain—Doxorubicin—uterine cancer	8.74e-05	0.000337	CcSEcCtD
Etoricoxib—Asthenia—Epirubicin—uterine cancer	8.57e-05	0.000331	CcSEcCtD
Etoricoxib—Pruritus—Epirubicin—uterine cancer	8.45e-05	0.000326	CcSEcCtD
Etoricoxib—Diarrhoea—Epirubicin—uterine cancer	8.17e-05	0.000315	CcSEcCtD
Etoricoxib—Hypersensitivity—Doxorubicin—uterine cancer	8.14e-05	0.000314	CcSEcCtD
Etoricoxib—Asthenia—Doxorubicin—uterine cancer	7.93e-05	0.000306	CcSEcCtD
Etoricoxib—Dizziness—Epirubicin—uterine cancer	7.9e-05	0.000305	CcSEcCtD
Etoricoxib—Pruritus—Doxorubicin—uterine cancer	7.82e-05	0.000302	CcSEcCtD
Etoricoxib—Vomiting—Epirubicin—uterine cancer	7.6e-05	0.000293	CcSEcCtD
Etoricoxib—Diarrhoea—Doxorubicin—uterine cancer	7.56e-05	0.000292	CcSEcCtD
Etoricoxib—Rash—Epirubicin—uterine cancer	7.53e-05	0.000291	CcSEcCtD
Etoricoxib—Dermatitis—Epirubicin—uterine cancer	7.53e-05	0.00029	CcSEcCtD
Etoricoxib—Headache—Epirubicin—uterine cancer	7.48e-05	0.000289	CcSEcCtD
Etoricoxib—Dizziness—Doxorubicin—uterine cancer	7.31e-05	0.000282	CcSEcCtD
Etoricoxib—Nausea—Epirubicin—uterine cancer	7.1e-05	0.000274	CcSEcCtD
Etoricoxib—Vomiting—Doxorubicin—uterine cancer	7.03e-05	0.000271	CcSEcCtD
Etoricoxib—Rash—Doxorubicin—uterine cancer	6.97e-05	0.000269	CcSEcCtD
Etoricoxib—Dermatitis—Doxorubicin—uterine cancer	6.96e-05	0.000269	CcSEcCtD
Etoricoxib—Headache—Doxorubicin—uterine cancer	6.92e-05	0.000267	CcSEcCtD
Etoricoxib—Nausea—Doxorubicin—uterine cancer	6.57e-05	0.000253	CcSEcCtD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	5.56e-05	0.00046	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SRD5A2—uterine cancer	5.51e-05	0.000455	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NDUFB11—uterine cancer	5.51e-05	0.000455	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—NRAS—uterine cancer	5.48e-05	0.000454	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AKR1B1—uterine cancer	5.48e-05	0.000453	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—STAR—uterine cancer	5.48e-05	0.000453	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TP53—uterine cancer	5.44e-05	0.00045	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	5.42e-05	0.000449	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—AKT1—uterine cancer	5.42e-05	0.000448	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.42e-05	0.000448	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—ESR2—uterine cancer	5.35e-05	0.000442	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.35e-05	0.000442	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	5.33e-05	0.000441	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AKR1C1—uterine cancer	5.26e-05	0.000436	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—HRAS—uterine cancer	5.22e-05	0.000431	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	5.17e-05	0.000428	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AKR1B1—uterine cancer	5.16e-05	0.000427	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—STAR—uterine cancer	5.16e-05	0.000427	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.11e-05	0.000423	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NDUFB11—uterine cancer	5.06e-05	0.000419	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SRD5A2—uterine cancer	5.06e-05	0.000419	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.05e-05	0.000418	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SRD5A2—uterine cancer	5.02e-05	0.000415	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NDUFB11—uterine cancer	5.02e-05	0.000415	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	4.9e-05	0.000405	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	4.89e-05	0.000405	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.88e-05	0.000403	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—AKR1C1—uterine cancer	4.8e-05	0.000397	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—KRAS—uterine cancer	4.72e-05	0.00039	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—ERBB2—uterine cancer	4.65e-05	0.000385	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—AKT1—uterine cancer	4.61e-05	0.000381	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.6e-05	0.000381	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—SOCS3—uterine cancer	4.57e-05	0.000378	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—TP53—uterine cancer	4.47e-05	0.00037	CbGpPWpGaD
Etoricoxib—MAPK14—Metabolism of mRNA—AKT1—uterine cancer	4.39e-05	0.000363	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—CDKN2B—uterine cancer	4.35e-05	0.00036	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—AKT1—uterine cancer	4.35e-05	0.00036	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—PIK3CA—uterine cancer	4.34e-05	0.000359	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—POLD1—uterine cancer	4.3e-05	0.000356	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SRD5A2—uterine cancer	4.29e-05	0.000355	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NDUFB11—uterine cancer	4.29e-05	0.000355	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.17e-05	0.000345	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	4.16e-05	0.000345	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—DCN—uterine cancer	4.16e-05	0.000344	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—ERBB2—uterine cancer	4.11e-05	0.00034	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—CTNNB1—uterine cancer	4.07e-05	0.000337	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AKR1C3—uterine cancer	4.05e-05	0.000335	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—POLD1—uterine cancer	4.05e-05	0.000335	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AKR1C1—uterine cancer	4.02e-05	0.000333	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—HRAS—uterine cancer	4.01e-05	0.000332	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKR1B1—uterine cancer	3.98e-05	0.000329	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—STAR—uterine cancer	3.98e-05	0.000329	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—SMAD3—uterine cancer	3.97e-05	0.000329	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PGR—uterine cancer	3.95e-05	0.000327	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.93e-05	0.000326	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.93e-05	0.000325	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.83e-05	0.000317	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—FGFR2—uterine cancer	3.81e-05	0.000315	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CDKN1B—uterine cancer	3.81e-05	0.000315	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AKR1C1—uterine cancer	3.79e-05	0.000313	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—EP300—uterine cancer	3.79e-05	0.000313	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—YWHAE—uterine cancer	3.77e-05	0.000312	CbGpPWpGaD
Etoricoxib—MAPK14—Metabolism of RNA—AKT1—uterine cancer	3.75e-05	0.000311	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—EP300—uterine cancer	3.71e-05	0.000307	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.7e-05	0.000306	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—AKR1C3—uterine cancer	3.7e-05	0.000306	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—STAR—uterine cancer	3.66e-05	0.000303	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKR1B1—uterine cancer	3.66e-05	0.000303	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKR1B1—uterine cancer	3.63e-05	0.0003	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—STAR—uterine cancer	3.63e-05	0.0003	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FBXW7—uterine cancer	3.61e-05	0.000299	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HMGA1—uterine cancer	3.6e-05	0.000298	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CTNNB1—uterine cancer	3.6e-05	0.000298	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.59e-05	0.000297	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—RRM2—uterine cancer	3.59e-05	0.000297	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—VEGFA—uterine cancer	3.59e-05	0.000297	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—AKT1—uterine cancer	3.54e-05	0.000293	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—NRAS—uterine cancer	3.54e-05	0.000293	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—VEGFA—uterine cancer	3.52e-05	0.000291	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—PTEN—uterine cancer	3.51e-05	0.00029	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—DCN—uterine cancer	3.48e-05	0.000288	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—NRAS—uterine cancer	3.47e-05	0.000287	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—RRM2—uterine cancer	3.37e-05	0.000279	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—EP300—uterine cancer	3.34e-05	0.000277	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.31e-05	0.000274	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SRD5A2—uterine cancer	3.31e-05	0.000274	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—FBXW7—uterine cancer	3.3e-05	0.000273	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP11A1—uterine cancer	3.28e-05	0.000271	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—DCN—uterine cancer	3.28e-05	0.000271	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—ESR1—uterine cancer	3.24e-05	0.000268	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STK11—uterine cancer	3.16e-05	0.000261	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—NRAS—uterine cancer	3.13e-05	0.000259	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.13e-05	0.000259	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—POLD1—uterine cancer	3.12e-05	0.000258	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKR1B1—uterine cancer	3.1e-05	0.000257	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—STAR—uterine cancer	3.1e-05	0.000257	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AKR1C3—uterine cancer	3.1e-05	0.000256	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP11A1—uterine cancer	3.09e-05	0.000255	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.07e-05	0.000254	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—KRAS—uterine cancer	3.05e-05	0.000252	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—KRAS—uterine cancer	2.99e-05	0.000247	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SOCS3—uterine cancer	2.96e-05	0.000245	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKR1C1—uterine cancer	2.92e-05	0.000242	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AKR1C3—uterine cancer	2.91e-05	0.000241	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—POLD1—uterine cancer	2.87e-05	0.000238	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—POLD1—uterine cancer	2.85e-05	0.000236	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CDH1—uterine cancer	2.84e-05	0.000235	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CDKN2B—uterine cancer	2.83e-05	0.000234	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF1R—uterine cancer	2.75e-05	0.000227	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—PIK3CA—uterine cancer	2.75e-05	0.000227	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—KRAS—uterine cancer	2.69e-05	0.000223	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKR1C1—uterine cancer	2.69e-05	0.000222	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.66e-05	0.00022	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—uterine cancer	2.66e-05	0.00022	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—RRM2—uterine cancer	2.6e-05	0.000215	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—HRAS—uterine cancer	2.59e-05	0.000214	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SMAD3—uterine cancer	2.58e-05	0.000214	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CDKN2B—uterine cancer	2.58e-05	0.000214	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—HRAS—uterine cancer	2.54e-05	0.00021	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—DCN—uterine cancer	2.53e-05	0.000209	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—PIK3CA—uterine cancer	2.47e-05	0.000205	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FGFR2—uterine cancer	2.47e-05	0.000204	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—POLD1—uterine cancer	2.43e-05	0.000201	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—STK11—uterine cancer	2.41e-05	0.0002	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP19A1—uterine cancer	2.41e-05	0.0002	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—RRM2—uterine cancer	2.39e-05	0.000198	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ERBB2—uterine cancer	2.39e-05	0.000198	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—STAR—uterine cancer	2.39e-05	0.000198	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.39e-05	0.000198	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP11A1—uterine cancer	2.38e-05	0.000197	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—RRM2—uterine cancer	2.37e-05	0.000196	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SMAD3—uterine cancer	2.36e-05	0.000195	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—DCN—uterine cancer	2.32e-05	0.000192	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—DCN—uterine cancer	2.3e-05	0.000191	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—HRAS—uterine cancer	2.29e-05	0.000189	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—AKT1—uterine cancer	2.29e-05	0.000189	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKR1C1—uterine cancer	2.28e-05	0.000188	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—STK11—uterine cancer	2.27e-05	0.000188	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP19A1—uterine cancer	2.27e-05	0.000188	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.26e-05	0.000187	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKR1C3—uterine cancer	2.25e-05	0.000186	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—FGFR2—uterine cancer	2.25e-05	0.000186	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—AKT1—uterine cancer	2.24e-05	0.000186	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CDKN1B—uterine cancer	2.22e-05	0.000183	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP11A1—uterine cancer	2.19e-05	0.000181	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP11A1—uterine cancer	2.17e-05	0.00018	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MTHFR—uterine cancer	2.16e-05	0.000179	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.16e-05	0.000179	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ESR1—uterine cancer	2.11e-05	0.000174	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CTNNB1—uterine cancer	2.09e-05	0.000173	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKR1C3—uterine cancer	2.07e-05	0.000171	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKR1C3—uterine cancer	2.05e-05	0.00017	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PTEN—uterine cancer	2.04e-05	0.000169	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—RRM2—uterine cancer	2.03e-05	0.000168	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—AKT1—uterine cancer	2.02e-05	0.000167	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—DCN—uterine cancer	1.97e-05	0.000163	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—EP300—uterine cancer	1.95e-05	0.000161	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—POLD1—uterine cancer	1.88e-05	0.000155	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL2—uterine cancer	1.86e-05	0.000154	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.86e-05	0.000154	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NRAS—uterine cancer	1.82e-05	0.000151	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MTHFR—uterine cancer	1.81e-05	0.00015	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.76e-05	0.000145	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.75e-05	0.000145	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—STK11—uterine cancer	1.75e-05	0.000145	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.75e-05	0.000145	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MTHFR—uterine cancer	1.71e-05	0.000141	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.64e-05	0.000136	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.61e-05	0.000133	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—STK11—uterine cancer	1.61e-05	0.000133	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.6e-05	0.000132	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—STK11—uterine cancer	1.6e-05	0.000132	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.6e-05	0.000132	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.57e-05	0.00013	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—KRAS—uterine cancer	1.57e-05	0.00013	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—RRM2—uterine cancer	1.57e-05	0.00013	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ERBB2—uterine cancer	1.55e-05	0.000128	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—DCN—uterine cancer	1.52e-05	0.000126	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.5e-05	0.000124	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL8—uterine cancer	1.47e-05	0.000121	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PIK3CA—uterine cancer	1.44e-05	0.000119	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CDKN1B—uterine cancer	1.43e-05	0.000119	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.43e-05	0.000118	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.43e-05	0.000118	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ERBB2—uterine cancer	1.41e-05	0.000117	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—STK11—uterine cancer	1.37e-05	0.000113	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.37e-05	0.000113	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CTNNB1—uterine cancer	1.35e-05	0.000112	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.35e-05	0.000112	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HRAS—uterine cancer	1.33e-05	0.00011	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTEN—uterine cancer	1.32e-05	0.000109	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MTHFR—uterine cancer	1.32e-05	0.000109	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CDKN1B—uterine cancer	1.31e-05	0.000108	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.28e-05	0.000106	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EP300—uterine cancer	1.26e-05	0.000104	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CTNNB1—uterine cancer	1.24e-05	0.000102	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.22e-05	0.000101	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MTHFR—uterine cancer	1.21e-05	0.0001	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PTEN—uterine cancer	1.2e-05	9.96e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MTHFR—uterine cancer	1.2e-05	9.93e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VEGFA—uterine cancer	1.19e-05	9.86e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NRAS—uterine cancer	1.18e-05	9.74e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—AKT1—uterine cancer	1.18e-05	9.73e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—AKT1—uterine cancer	1.17e-05	9.68e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.16e-05	9.6e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—EP300—uterine cancer	1.15e-05	9.5e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NRAS—uterine cancer	1.07e-05	8.89e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.06e-05	8.75e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—STK11—uterine cancer	1.05e-05	8.72e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.05e-05	8.72e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MTHFR—uterine cancer	1.03e-05	8.49e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KRAS—uterine cancer	1.01e-05	8.39e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PTEN—uterine cancer	1.01e-05	8.34e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—EP300—uterine cancer	9.62e-06	7.96e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTEN—uterine cancer	9.49e-06	7.85e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PIK3CA—uterine cancer	9.31e-06	7.7e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—KRAS—uterine cancer	9.25e-06	7.65e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—EP300—uterine cancer	9.05e-06	7.49e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.04e-06	7.48e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—uterine cancer	9.01e-06	7.45e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HRAS—uterine cancer	8.62e-06	7.13e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PIK3CA—uterine cancer	8.5e-06	7.03e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MTHFR—uterine cancer	7.92e-06	6.55e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HRAS—uterine cancer	7.86e-06	6.5e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AKT1—uterine cancer	7.61e-06	6.29e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTEN—uterine cancer	7.32e-06	6.06e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3CA—uterine cancer	7.11e-06	5.89e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—EP300—uterine cancer	6.99e-06	5.78e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—AKT1—uterine cancer	6.94e-06	5.74e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTEN—uterine cancer	6.74e-06	5.57e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3CA—uterine cancer	6.7e-06	5.54e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTEN—uterine cancer	6.68e-06	5.53e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—EP300—uterine cancer	6.42e-06	5.32e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—EP300—uterine cancer	6.37e-06	5.27e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AKT1—uterine cancer	5.81e-06	4.81e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTEN—uterine cancer	5.71e-06	4.72e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AKT1—uterine cancer	5.47e-06	4.53e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—EP300—uterine cancer	5.44e-06	4.5e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3CA—uterine cancer	5.17e-06	4.27e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3CA—uterine cancer	4.75e-06	3.93e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3CA—uterine cancer	4.71e-06	3.9e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTEN—uterine cancer	4.4e-06	3.64e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKT1—uterine cancer	4.22e-06	3.49e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—EP300—uterine cancer	4.2e-06	3.48e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3CA—uterine cancer	4.03e-06	3.33e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKT1—uterine cancer	3.88e-06	3.21e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKT1—uterine cancer	3.85e-06	3.18e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKT1—uterine cancer	3.29e-06	2.72e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.11e-06	2.57e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKT1—uterine cancer	2.54e-06	2.1e-05	CbGpPWpGaD
